Yumiko Maeda

发表

Prognostic impact of adding bevacizumab to carboplatin and paclitaxel for recurrent, persistent, or metastatic cervical cancer.

H. Yagi, Kiyoko Kato, K. Asanoma, 2022, Taiwanese journal of obstetrics & gynecology.